Engineers multi-receptor T-cell therapies to target and destroy solid oncology tumors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Tactiva Therapeutics is an immuno-oncology company developing next-generation adoptive cell therapy strategies that use a dual T cell receptor approach to deliver potent and sustained immune attacks on cancer cells. Their platform harnesses both CD4 and CD8 T cell receptors, as well as hematopoietic stem cell-derived T cells, to provide durable remission for cancer patients by specifically targeting and destroying tumor cells.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Tactiva Therapeutics Management Team
Investors
Efung Capital
Panacea Ventures
Vi-Ventures
Tactiva Therapeutics Valuations & Financials
View real-time NPM data on Tactiva Therapeutics stock including daily Tactiva Therapeutics stock price estimates, valuation history, and historical share price information. Access Tactiva Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Tactiva Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Tactiva Therapeutics? Get in touch to learn more.
Similar Companies
like Tactiva Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Sutro
AI & Machine Learning
Enables users to create custom applications through natural language prompts, leveraging AI to facilitate rapid, no-code software development.
Hassett Homes
A construction company that builds contemporary, high-end homes, aiming to modernize the housing industry and create residences that clients adore.
MightyMeld
Enterprise Software
Enable a live visual interface that updates your UI code with intuitive drag-and-drop and AI-powered styling.
Trunk Tools
Delivers AI-powered software that automates document search, review, and workflows to boost productivity and safety on construction sites.
Phyla
Healthcare & Life Sciences
Harnessing targeted phage therapy for acne care, clearing breakouts gently while preserving the skin’s natural microbial balance.
Exosite
Builds customizable Internet of Things platforms to streamline machine data collection and remote asset management.
Culinary Sciences
Consumer
Empowers food processing with dual-mode vacuum cooling and flavor infusion that boosts efficiency while preserving quality.
Tetrate
Enables platform teams and developers to securely modernize and manage infrastructure across multi-cloud environments.
FAQ
We have answers
Tactiva Therapeutics stock does not trade on public stock exchanges. Tactiva Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Tactiva Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Tactiva Therapeutics Stock does not trade on public stock exchanges. In order to sell Tactiva Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Tactiva Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Tactiva Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Tactiva Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Tactiva Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Tactiva Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Tactiva Therapeutics is a private company and has not had an IPO. There is currently no Tactiva Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Tactiva Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
